Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
1,925.90
1,506.67
1,272.30
1,071.71
1,001.70
700.34
665.83
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,925.90
1,506.67
1,272.30
1,071.71
1,001.70
700.34
665.83
Raw Material Cost
654.36
521.15
507.42
461.08
452.89
269.16
268.45
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
249.14
185.74
167.09
134.23
172.08
175.23
161.10
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
41.17
39.57
57.41
64.85
35.89
28.78
40.07
Selling and Distribution Expenses
948.53
802.80
676.82
531.61
499.34
396.76
368.40
Other Expenses
-29.03
-22.53
-22.45
-19.91
-20.80
-20.40
-20.12
Total Expenditure (Excl Depreciation)
1,602.89
1,323.95
1,184.24
992.70
952.23
665.93
636.85
Operating Profit (PBDIT) excl Other Income
323
182.7
88.10000000000001
79
49.5
34.4
29
Other Income
19.33
3.82
1.83
1.78
0.68
0.17
-7.75
Operating Profit (PBDIT)
442.46
272.92
163.60
157.28
128.54
105.16
94.05
Interest
41.17
39.57
57.41
64.85
35.89
28.78
40.07
Exceptional Items
0.00
0.00
0.00
0.01
0.00
0.01
-0.00
Gross Profit (PBDT)
1,271.54
985.52
764.89
610.62
548.81
431.18
397.38
Depreciation
100.12
86.38
73.70
76.49
78.51
70.58
72.83
Profit Before Tax
301.17
146.97
32.49
15.95
14.14
5.80
-18.85
Tax
85.16
30.79
7.86
28.67
-2.27
3.50
-13.10
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
216.01
116.18
24.63
-12.73
16.41
2.30
-5.75
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
216.01
116.18
24.63
-12.73
16.41
2.30
-5.75
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
216.01
116.18
24.63
-12.73
16.41
2.30
-5.75
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,148.02
912.46
798.56
473.61
494.37
476.51
472.85
Earnings per share (EPS)
0.5
0.27
0.06
-0.03
0.04
0.01
-0.01
Diluted Earnings per share
0.5
0.27
0.06
-0.03
0.04
0.01
-0.01
Operating Profit Margin (Excl OI)
16.77%
12.13%
6.92%
7.37%
4.93%
4.91%
4.35%
Gross Profit Margin
20.84%
15.49%
8.35%
8.63%
9.25%
10.91%
8.11%
PAT Margin
11.22%
7.71%
1.94%
-1.19%
1.64%
0.33%
-0.86%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 27.82% vs 18.42% in Mar 2025
Consolidate Net Profit
YoY Growth in year ended Mar 2026 is 85.89% vs 372.36% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 57.23% vs 66.32% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 4.04% vs -31.01% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has improved from Mar 2025
Compare Annual Results Of Singhe Hospitals PLC With
Figures in Million
Consolidate Annual Results
Change(LKR)
Change(%)
Net Sales
1,925.90
14,473.92
-12,548.02
-86.69%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,925.90
14,473.92
-12,548.02
-86.69%
Raw Material Cost
654.36
8,417.10
-7,762.74
-92.23%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
249.14
3,801.86
-3,552.72
-93.45%
Power Cost
0
0
0.00
Manufacturing Expenses
41.17
54.54
-13.37
-24.51%
Selling and Distribution Expenses
948.53
2,941.41
-1,992.88
-67.75%
Other Expenses
-29.03
-385.64
356.61
92.47%
Total Expenditure (Excl Depreciation)
1,602.89
11,358.52
-9,755.63
-85.89%
Operating Profit (PBDIT) excl Other Income
323.01
3,115.40
-2,792.39
-89.63%
Other Income
19.33
-230.94
250.27
108.37%
Operating Profit (PBDIT)
442.46
3,745.61
-3,303.15
-88.19%
Interest
41.17
54.54
-13.37
-24.51%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
1,271.54
6,056.82
-4,785.28
-79.01%
Depreciation
100.12
861.15
-761.03
-88.37%
Profit Before Tax
301.17
2,829.92
-2,528.75
-89.36%
Tax
85.16
885.55
-800.39
-90.38%
Provisions and contingencies
0
0
0.00
Profit After Tax
216.01
1,944.37
-1,728.36
-88.89%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
216.01
1,944.37
-1,728.36
-88.89%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
216.01
1,944.37
-1,728.36
-88.89%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,148.02
15,374.33
-14,226.31
-92.53%
Earnings per share (EPS)
0.50
8.69
-8.19
-94.25%
Diluted Earnings per share
0.50
8.69
-8.19
-94.25%
Operating Profit Margin (Excl OI)
16.77%
21.52%
0.00
-4.75%
Gross Profit Margin
20.84%
25.50%
0.00
-4.66%
PAT Margin
11.22%
13.43%
0.00
-2.21%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 192.59 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 27.82% vs 18.42% in Mar 2025
Annual - Consolidate Net Profit
Consolidate Net Profit 21.60 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 85.89% vs 372.36% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 42.31 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 57.23% vs 66.32% in Mar 2025
Annual - Interest
Interest 4.12 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 4.04% vs -31.01% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.77%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has improved from Mar 2025






